Compounded Medication

BPC-157 + TB-500 (combo)

This is a 1:1 co-formulation of two synthetic peptides: BPC-157 (a pentadecapeptide related to a gastric protective protein) and TB-500 (a fragment of the protein Thymosin Beta-4). Both have been studied in preclinical literature in connection with complementary tissue-repair signaling pathways.
MediVera compounding pharmacist in grey scrubs reviewing a prescription on a clipboard in front of pharmacy shelves stocked with medication bottles

About BPC-157 + TB-500 (combo)

This is a 1:1 co-formulation of two synthetic peptides: BPC-157 (a pentadecapeptide related to a gastric protective protein) and TB-500 (a fragment of the protein Thymosin Beta-4). Both peptides have been studied in preclinical literature in connection with complementary tissue-repair signaling pathways, one examined more in localized contexts and the other in systemic contexts. Any activity described is attributed to the peptides as studied in laboratory and animal models, not to any specific compounded preparation.

This peptide class is currently under evolving regulatory review. Information listed here is for educational purposes only and is not intended as medical advice or a promotion of any specific product. Compounded medications are not evaluated by the FDA for safety or efficacy. This information does not imply availability of BPC-157 + TB-500 combination through MediVera Compounding Pharmacy™.

Our Current Peptide Offerings

*Compounded medications are prepared based on a healthcare provider’s prescription to meet individual patient needs. These medications are not FDA-approved, and no claims are made regarding their safety, efficacy, or quality. While we offer compounded medications tailored to individual needs, we also have commercially available drugs for patients when appropriate. All doses listed are common doses; customized medication strengths are also available as prescribed by a licensed provider.

Related Products

Learn More

How Patients Can Engage With Us